ADRIAN D SANDLER

Summary

Country: USA

Publications

  1. doi Open-label use of placebos in the treatment of ADHD: a pilot study
    A D Sandler
    Olson Huff Center, Mission Children s Hospital, Asheville, NC, and Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Child Care Health Dev 34:104-10. 2008
  2. pmc Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?
    ADRIAN D SANDLER
    Olson Huff Center, Mission Children s Hospital, Asheville, NC 28803, USA
    J Dev Behav Pediatr 31:369-75. 2010
  3. ncbi Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder
    A D Sandler
    Olson Huff Center for Child Development, Thoms Rehabilitation Hospital, Asheville, NC 28803, USA
    N Engl J Med 341:1801-6. 1999
  4. ncbi Placebo effects in developmental disabilities: implications for research and practice
    Adrian Sandler
    Department of Pediatrics, University of North Carolina at Chapel Hill, 28801, USA
    Ment Retard Dev Disabil Res Rev 11:164-70. 2005
  5. doi Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD
    A Sandler
    Olson Huff Center, Mission Children s Hospital, Asheville, NC, USA, and Department of Pediatrics, University of North Carolina at Chapel Hill, NC 28803, USA
    Child Care Health Dev 34:111-20. 2008
  6. doi Children with spina bifida: key clinical issues
    ADRIAN D SANDLER
    Olson Huff Center, Mission Children s Hospital, 11 Vanderbilt Park Drive, Asheville, NC 28803, USA
    Pediatr Clin North Am 57:879-92. 2010

Collaborators

Detail Information

Publications6

  1. doi Open-label use of placebos in the treatment of ADHD: a pilot study
    A D Sandler
    Olson Huff Center, Mission Children s Hospital, Asheville, NC, and Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Child Care Health Dev 34:104-10. 2008
    ..This study examined short-term efficacy, side effects and acceptability of a placebo treatment procedure designed to maintain children with attention deficit hyperactivity disorder (ADHD) on 50% of their usual stimulant dose...
  2. pmc Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?
    ADRIAN D SANDLER
    Olson Huff Center, Mission Children s Hospital, Asheville, NC 28803, USA
    J Dev Behav Pediatr 31:369-75. 2010
    ..The primary aim was to determine the efficacy, side effects, and acceptability of a novel conditioned placebo dose reduction procedure...
  3. ncbi Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder
    A D Sandler
    Olson Huff Center for Child Development, Thoms Rehabilitation Hospital, Asheville, NC 28803, USA
    N Engl J Med 341:1801-6. 1999
    ..After recent publicity about a child with autism whose condition markedly improved after a single dose of secretin, thousands of children with autistic disorders may have received secretin injections...
  4. ncbi Placebo effects in developmental disabilities: implications for research and practice
    Adrian Sandler
    Department of Pediatrics, University of North Carolina at Chapel Hill, 28801, USA
    Ment Retard Dev Disabil Res Rev 11:164-70. 2005
    ..An innovative approach to the ethical use of placebo is proposed...
  5. doi Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD
    A Sandler
    Olson Huff Center, Mission Children s Hospital, Asheville, NC, USA, and Department of Pediatrics, University of North Carolina at Chapel Hill, NC 28803, USA
    Child Care Health Dev 34:111-20. 2008
    ..This paper focuses on the qualitative data from the study...
  6. doi Children with spina bifida: key clinical issues
    ADRIAN D SANDLER
    Olson Huff Center, Mission Children s Hospital, 11 Vanderbilt Park Drive, Asheville, NC 28803, USA
    Pediatr Clin North Am 57:879-92. 2010
    ..This article also summarizes some of the key clinical issues in the care of children with this complex birth defect...